781-40-8 Usage
Description
(1E)-3,4-dihydrophenanthren-1(2H)-one oxime, also known as 1,2-Dihydrophenanthren-1-one oxime, is a derivative of phenanthrene and belongs to the oxime class of organic compounds. It has the molecular formula C14H11NO and a molecular weight of 209.25 g/mol. This pale yellow solid possesses reactivity and properties that make it suitable for various synthetic applications in the pharmaceutical and chemical industries. Its potential uses include the production of pharmaceutical drugs and other organic compounds, and it may also have biological activities that warrant further research and development.
Uses
Used in Pharmaceutical Industry:
(1E)-3,4-dihydrophenanthren-1(2H)-one oxime is used as a synthetic intermediate for the production of pharmaceutical drugs. Its unique structure and reactivity allow for the creation of new drug molecules with potential therapeutic applications.
Used in Chemical Industry:
In the chemical industry, (1E)-3,4-dihydrophenanthren-1(2H)-one oxime serves as a building block for the synthesis of various organic compounds. Its versatility in chemical reactions enables the development of new materials and products with diverse applications.
Used in Research and Development:
(1E)-3,4-dihydrophenanthren-1(2H)-one oxime is used as a subject of interest for further research and development due to its potential biological activities. Scientists and researchers explore its properties and interactions to uncover new applications and insights into its capabilities.
Check Digit Verification of cas no
The CAS Registry Mumber 781-40-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,8 and 1 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 781-40:
(5*7)+(4*8)+(3*1)+(2*4)+(1*0)=78
78 % 10 = 8
So 781-40-8 is a valid CAS Registry Number.
781-40-8Relevant articles and documents
N-substituted naphthofused lactams
-
, (2008/06/13)
The present invention relates to novel N-substituted naphthofused lactams and salts thereof of the formula STR1 Compounds of the general formula I possess the ability to stimulate the release of endogenous growth hormone. Thus, these compounds may be used